STAIR Washington


STAIR Baltimore


STAIR Forum


STAIR Consensus


STAIR FDA Panel


 
STAIR
Perfusion weighted MRI

Diffusion weighted MRI

Perfusion CT

MR Angiography

 

Images kindly provided by the department of Neurology and Radiology, CHUV, Lausanne, Switzerland
Stroke Treatment Academic Industry Roundtable

 
The STAIR consensus conferences and STAIR online are intended to improve our understanding of issues critical to stroke drug and device development and advance knowledge essential to the successful development of new acute stroke treatments. The STAIR - Stroke Treatment Academic Industry Roundtable - Consensus Conferences are unique in a number of ways.
  • STAIR is an invitation only conference, which assembles a select group of leading scientists from industry, academia and government.
  • STAIR encourages formal and informal exchanges and a spirit of collegiality among participants to stimulate candid and open idea exchange, which participants acknowledge is confidential and not for publication outside of the conference.
  • Participants openly address critical questions and issues, intended to explore and examine the current state of acute stroke treatment trials.
  • During the conference, a consensus process is initiated, which results in the development of recommendataion which are vital to improving stroke drug development, and from which a manuscript is created and published in a leading medical journal.
  • STAIR strives to be a positive influence on stroke treament research by embracing a diversity of approaches and concepts.
  • STAIR provides a forum for networking amongst participants from industry, academia and government.
  • In addition to the STAIR meetings, a STEPS -- Stem Cell Therapies as an Emerging Paradigm in Stroke consensus conference was convened in 2007 following the STAIR model.

All conference participants are given the opportunity to engage in this collaborative process resulting in a consensus statement, which is submitted to a major scientific journal for publication. The STAIR goal is to develop recommendations that maximize opportunities for successfully, efficiently and rapidly mounting and completing acute stroke studies.

Six STAIR and one STEPS consensus conferences have been held. The consensus statements produced from STAIR conferences I through V, have all been published in the journal Stroke.

The published recommendations are widely referenced and applied to the process of stroke drug/device development. These STAIR consensus statements are made available here. Upon their publication, we'll post the STAIR VI and STEPS consensus manuscripts here as well.

 
 
 
  The information contained in this website reflects opinions of STAIR participants regarding the process of conducting research and development into new and prospective drugs for the treatment of stroke. The information also represents the views of selected individuals and is not intended to be a substitute for rigorous independent testing and development of individual compounds by research sponsors, nor should the information and opinions be construed as official government regulations or official interpretations of government regulations. All government regulations, their interpretations and their applications to specific research studies and clinical trials are subject to individual deliberations between study sponsors and government agencies. The information contained in this website is not intended to be a substitute for sound medical advice, clinical judgement or informed treatment decisions.    
 
 
 
© 2006 STAIR - All Rights Reserved